Evidence map›Paper›PMID 39863330›Full record

ArticleThe journal of prevention of Alzheimer's disease2025

Corrigendum to "Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study" [The Journal of Prevention of Alzheimer's Disease 2024;11(3):567-581].

B Souchet, A Michaïl, M Heuillet, A Dupuy-Gayral, E Haudebourg, C Pech, A Berthemy, F Autelitano, B Billoir, K Domoto-Reilly and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of prevention of Alzheimer's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

B SouchetAgenT, 4 rue Pierre Fontaine, 91000 Evry-Courcouronnes, France.
A MichaïlAgenT, 4 rue Pierre Fontaine, 91000 Evry-Courcouronnes, France.
M HeuilletEVOTEC, 195 Route d'Espagne, 31100 Toulouse, France.
A Dupuy-GayralEVOTEC, 195 Route d'Espagne, 31100 Toulouse, France.
E HaudebourgEVOTEC, 195 Route d'Espagne, 31100 Toulouse, France.
C PechEVOTEC, 195 Route d'Espagne, 31100 Toulouse, France.
A BerthemyEVOTEC, 195 Route d'Espagne, 31100 Toulouse, France.
F AutelitanoEVOTEC, 195 Route d'Espagne, 31100 Toulouse, France.
B BilloirAgenT, 4 rue Pierre Fontaine, 91000 Evry-Courcouronnes, France.
K Domoto-ReillyDepartment of Neurology, University of Washington, 1410 NE Campus Pkwy, Seattle, WA 98195, United States.
C FowlerDepartment of Molecular Imaging & Therapy, Austin Health, Austin Hospital, Heidelberg, VIC 3084, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia.
T RabowskiDepartment of Neurology, University of Washington, 1410 NE Campus Pkwy, Seattle, WA 98195, United States.
S JayadevDepartment of Neurology, University of Washington, 1410 NE Campus Pkwy, Seattle, WA 98195, United States.
C L MastersThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia.
J BraudeauAgenT, 4 rue Pierre Fontaine, 91000 Evry-Courcouronnes, France. Electronic address: jerome.braudeau@agent-biotech.com.

Funding

University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Amanda D. Boyd · 2020 to 2026
$29.0M
NIA NIH HHS P30 AG066509
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39863330
PMCPMC12184006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.